Vimarsana
Biggest News Aggregation in the World

Optimal Duration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Optimal Duration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Optimal Duration Today - Breaking & Trending Today

Leadership Strategy in Geopolitical Unrest: Contours of Duty Of Care - Vimarsana News

Leadership Strategy in Geopolitical Unrest: Contours of Duty Of Care

Steering an organization through challenging times intersects business leadership, geopolitics, and the Board’s duty of care.

Source: forbes.com
Aspirin-Free Strategy Not Superior After Percutaneous Coronary Intervention - Vimarsana News

Aspirin-Free Strategy Not Superior After Percutaneous Coronary Intervention

An aspirin-free strategy following percutaneous coronary intervention was found to not be superior for 1-month outcomes.

Long-term Clopidogrel Has Advantages After Coronary Stenting - Vimarsana News

Long-term Clopidogrel Has Advantages After Coronary Stenting

Clopidogrel after PCI was noninferior to aspirin for net adverse clinical events but superior in reducing secondary endpoints of stroke and MI, in 5-year STOPDAPT-2 results.

WHO excludes weight loss drugs from essential medicines list - Vimarsana News

WHO excludes weight loss drugs from essential medicines list

The WHO has decided to not add GLP-1 receptor agonists indicated for weight loss to its 2023 essential medicines list. Data are lacking on long term efficacy, the WHO said.

Clopidogrel Monotherapy and Bleeding Risk Post-PCI in Patients With Diabetes - Vimarsana News

Clopidogrel Monotherapy and Bleeding Risk Post-PCI in Patients With Diabetes

Clopidogrel monotherapy after 1 month of DAPT following PCI decreases risk for major bleeding regardless of if a patient has diabetes.